Abnb Access Fund I Llc
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Abnb Access Fund I Llc stock price vs AMGN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMGN's multiple
Needs Annual EPS.
Implied fair value · at Abnb Access Fund I Llc's multiple
Needs Abnb Access Fund I Llc P/E.
Engine logicAbnb Access Fund I Llcvalued onAMGN’smultiple
Metric by metric
Snapshot Sep 8, 2026, 2:38 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Abnb Access Fund I Llc Latest annual filing · AMGN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 78% equity / 22% debt · EV / Revenue 7.17x · EV / EBITDA 18.78x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ABNB ACCESS FUND I LLC · implied price per share
Reporting currency could not be verified.
Amgen Inc. · implied price per share
Bear
$121.60
Base
$161.79
Bull
$216.01
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Abnb Access Fund I Llc · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
6.84x
Net debt / EBITDA
Leverage against operating earnings
—
3.57x
Cash and equivalents
Liquid reserves on the balance sheet
—
$9.13B
Total debt
Interest-bearing obligations outstanding
—
$59.20B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
REGENERON PHARMACEUTICALS, INC.
Abnb Access Fund I Llc vs REGN
BIOGEN INC.
Abnb Access Fund I Llc vs BIIB
VERTEX PHARMACEUTICALS INC / MA
Abnb Access Fund I Llc vs VRTX
Gilead Sciences, Inc.
Abnb Access Fund I Llc vs GILD
Moderna, Inc.
Abnb Access Fund I Llc vs MRNA
Eli Lilly and Company
Abnb Access Fund I Llc vs LLY
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.